Axcella Health Stock Price

-0.07 (-2.36%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 51,291
Bid Price 2.77
Ask Price 3.00
News -
Day High 2.9792


52 Week Range


Day Low 2.86
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Axcella Health Inc AXLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -2.36% 2.90 17:00:01
Open Price Low Price High Price Close Price Prev Close
2.90 2.86 2.9792 2.90 2.97
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
162 51,291 $ 2.91 $ 149,005 - 2.75 - 6.84
Last Trade Time Type Quantity Stock Price Currency
13:00:00 477 $ 2.90 USD


Draw Mode:

Axcella Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 105.70M 36.45M 16.26M $ - $ - -1.86 -1.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 2.70%

more financials information »

Axcella Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AXLA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.973.042.862.9547,253-0.07-2.36%
1 Month3.333.332.863.1190,745-0.43-12.91%
3 Months3.654.39992.753.33138,423-0.75-20.55%
6 Months3.065.902.754.11224,829-0.16-5.23%
1 Year5.646.842.754.37155,031-2.74-48.58%
3 Years15.1215.942.255.08135,322-12.22-80.82%
5 Years15.1215.942.255.08135,322-12.22-80.82%

Axcella Health Description

Axcella Health Inc a biotechnology company focused on treating complex diseases and improve health using endogenous metabolic modulator, or EMM, compositions. Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. The company's pipeline includes lead therapeutic candidates, AXA1665 for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125 for non-alcoholic steatohepatitis.
Your Recent History
Axcella He..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211127 08:00:02